Logo wahanariau.com
  2. New jersey

New jersey

Index
Globenewswire

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

Senin, 02 Juni 2025 - 03:23:09 Wib
Globenewswire

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with T

Senin, 02 Juni 2025 - 03:21:53 Wib
Globenewswire

Verisk Welcomes Christopher Perry and Sabra Purtill to its Board of Directors

Kamis, 22 Mei 2025 - 04:00:33 Wib
Globenewswire

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

Senin, 05 Mei 2025 - 21:43:51 Wib
Globenewswire

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

Jumat, 02 Mei 2025 - 20:41:20 Wib
Globenewswire

Verisk Unveils First-of-Its-Kind SRCC Catastrophe Model for the U.S. to Quantify Political Violence Risks

Rabu, 30 April 2025 - 22:17:33 Wib
Globenewswire

Trigyn Technologies Appoints Vikram Chandna as Chief Executive Officer

Selasa, 29 April 2025 - 03:14:06 Wib
Globenewswire

Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase

Selasa, 29 April 2025 - 03:04:45 Wib
Globenewswire

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

Selasa, 08 April 2025 - 03:52:58 Wib
Globenewswire

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention

Selasa, 08 April 2025 - 03:50:43 Wib
Globenewswire

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

Selasa, 01 April 2025 - 22:51:43 Wib
Globenewswire

Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure

Jumat, 28 Maret 2025 - 22:14:17 Wib
Globenewswire

UPDATE -- RAM Photonics Industrial Launches Mass Production of 2D Fiber Arrays for AI and DC

Sabtu, 22 Maret 2025 - 22:42:03 Wib
Globenewswire

Verisk Nominates Christopher Perry and Sabra Purtill to the Company’s Board of Directors

Sabtu, 22 Maret 2025 - 22:34:20 Wib
Globenewswire

Folk Maritime Becomes Middle East’s First Dry Container Fleet to Deploy ORBCOMM®’s Smart Container Technology

Rabu, 19 Maret 2025 - 05:03:48 Wib
Globenewswire

Vanotech Appoints Matthew Schiller to Lead Business Development

Kamis, 13 Maret 2025 - 18:30:00 Wib
Globenewswire

ORBCOMM® Announces OGx Enhancements to Improve Satellite IoT Accessibility

Selasa, 11 Maret 2025 - 22:37:27 Wib
Globenewswire

Synchronoss Memperkenalkan Capsyl Cloud di MWC Barcelona – Solusi Cloud Pribadi Turn-Key untuk Operator Global

Rabu, 05 Maret 2025 - 04:06:21 Wib
Globenewswire

Synchronoss Unveils Capsyl Cloud at MWC Barcelona – A Turn-Key Personal Cloud Solution for Global Operators

Selasa, 04 Maret 2025 - 05:41:52 Wib
Globenewswire

Horizon Group USA Names Big Wheel Toys as Australian Distributor

Senin, 03 Maret 2025 - 05:21:20 Wib
Globenewswire

Synchronoss Technologies Mengumumkan Tanggal Panggilan Konferensi Laporan Pendapatan Kuartal Keempat dan Tahun Penuh 2024

Jumat, 28 Februari 2025 - 00:04:29 Wib
Globenewswire

Synchronoss Technologies Announces Fourth Quarter and Full Year 2024 Earnings Call Date

Rabu, 26 Februari 2025 - 11:17:58 Wib
Globenewswire

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY(R) (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder

Rabu, 26 Februari 2025 - 11:16:38 Wib
Globenewswire

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

Sabtu, 22 Februari 2025 - 14:30:00 Wib
Globenewswire

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

Rabu, 12 Februari 2025 - 18:30:00 Wib